| | Class 2 Device Recall ThromboMAX with Calcium |  |
| Date Initiated by Firm | October 27, 2004 |
| Date Posted | November 30, 2004 |
| Recall Status1 |
Terminated 3 on July 25, 2005 |
| Recall Number | Z-0261-05 |
| Recall Event ID |
30354 |
| 510(K)Number | K972796 |
| Product Classification |
Test, Time, Prothrombin - Product Code GJS
|
| Product | AMAX ThromboMAX with Calcium, 10x4ml vials. Catalog #T9902. Lyophilized extract of rabbit brain with buffer, stabilizers and calcium chloride. Responsible firm on the label: Trinity Biotech PLC, IDA Business Park, Bray, County Wicklow, Ireland. USA Enquiries - Trinity Biotech USA, 1930 Innerbelt Business Center Drive, St. Louis, MO 63114, USA. |
| Code Information |
M13906, Exp. 6/14/06 |
| FEI Number |
1318354
|
Recalling Firm/ Manufacturer |
Trinity Biotech USA 2823 Girts Rd Jamestown NY 14701-9666
|
| For Additional Information Contact | Vicki Lehman 800-325-3424 Ext. 228 |
Manufacturer Reason for Recall | Prolongation of Prothrombin times in patient samples, resulting in a falsely elevated INR value. |
FDA Determined Cause 2 | Other |
| Action | Letters dated 11/1/2004 with instructions to (1) Discard remaining kits; (2) notify end-users; (3) Evaluate patient records when the kits were used to monitor Oral Anti-coagulant Therapy. |
| Quantity in Commerce | 1,183 kits |
| Distribution | Trinity Biotech, Jamestown, NY sold product to 87 customers: 10 distributors (7 in U.S. & 3 foreign); 1 exporter; and 76 end users. 84 of those customers are located in the United States. There is one consignee in Canada, one in Brazil, and one in Venezuela. In addition, the manufacturer in Ireland sold additional units of this lot to other countries. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = GJS
|
|
|
|